Qualitative methods in a randomised controlled trial: the role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool by Murtagh MJ et al.
doi: 10.1136/qshc.2006.018499
 2007 16: 224-229Qual Saf Health Care
 
M J Murtagh, R G Thomson, C R May, et al.
 
support tool
the intervention in one arm of a trial of a decision 
evaluation in providing evidence to discontinue
trial: the role of an integrated qualitative process 
Qualitative methods in a randomised controlled
 http://qshc.bmj.com/content/16/3/224.full.html
Updated information and services can be found at: 
These include:
References
 http://qshc.bmj.com/content/16/3/224.full.html#related-urls
Article cited in: 
 
 http://qshc.bmj.com/content/16/3/224.full.html#ref-list-1
This article cites 17 articles, 8 of which can be accessed free at:
service
Email alerting
the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the box at
Notes
 http://qshc.bmj.com/cgi/reprintform
To order reprints of this article go to: 
 http://qshc.bmj.com/subscriptions
 go to: Quality and Safety in Health CareTo subscribe to 
 group.bmj.com on February 23, 2010 - Published by qshc.bmj.comDownloaded from 
DEVELOPING RESEARCH AND PRACTICE
Qualitative methods in a randomised controlled trial: the role
of an integrated qualitative process evaluation in providing
evidence to discontinue the intervention in one arm of a trial of
a decision support tool
M J Murtagh, R G Thomson, C R May, T Rapley, B R Heaven, R H Graham, E F Kaner, L Stobbart,
M P Eccles
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for
authors’ affiliations
. . . . . . . . . . . . . . . . . . . . . . . .
Correspondence to:
Dr M J Murtagh, Institute of
Health and Society,
Newcastle University,
Framlington Place,
Newcastle upon Tyne NE2
4HH, UK; m.j.murtagh@
newcastle.ac.uk
Accepted 5 March 2007
. . . . . . . . . . . . . . . . . . . . . . . .
Qual Saf Health Care 2007;16:224–229. doi: 10.1136/qshc.2006.018499
Objective: To understand participants’ experiences and understandings of the interventions in the trial of a
computerised decision support tool in patients with atrial fibrillation being considered for anti-coagulation
treatment.
Design: Qualitative process evaluation carried out alongside the trial: non-participant observation and
semistructured interviews.
Participants: 30 participants aged .60 years taking part in the trial of a computerised decision support tool.
Results: Qualitative evidence provided the rationale to undertake a decision to discontinue one arm of the trial
on the basis that the intervention in that arm, a standard gamble values elicitation exercise was causing
confusion and was unlikely to produce valid data on participant values.
Conclusions: Qualitative methods used alongside a trial allow an understanding of the process and progress
of a trial, and provide evidence to intervene in the trial if necessary, including evidence for the rationale to
discontinue an intervention arm of the trial.
Q
ualitative methods are an increasing element of the
development of randomised controlled trials (RCTs),
particularly those of complex interventions where the
conduct of the intervention is mediated by human behaviour.
Qualitative methods are advocated in the pre-trial development
phase of complex interventions and during and after the trial to
facilitate interpretations of trial results.1 2 These recommendations
form part of the guidance for the use of qualitative methods in
RCTs in the Medical Research Council guidance, A framework for
development and evaluation of RCTs of complex interventions to improve
health.3 In this paper, we illustrate an additional use for qualitative
methods—that is, qualitative methods used alongside a trial may
provide evidence to intervene in a trial if necessary, including
evidence for the rationale to discontinue a trial intervention arm.
Although qualitative evidence has been used elsewhere to inform
the discontinuation/continuation of a drug trial,4 this is the first
reported use of an integrated and coterminous qualitative process
evaluation to inform the conduct and continuation of an RCT of a
complex behavioural intervention. We present here qualitative
analysis derived from a qualitative study of the Decision Analysis
in Routine Treatment Study II (DARTSII) efficacy trial. This
analysis allowed us to make a decision to discontinue one arm of
the trial on the basis that a major component of the intervention, a
standard gamble values elicitation exercise, was confusing to most
participants. Further, the outputs of the standard gamble did not
validly represent participant values as intended. We argue that
without the qualitative evidence we might not have been able to
identify the problem at an early stage and, crucially, we would not
have been able to justify a decision to suspend that arm.
METHODS
The efficacy trial
To assist both doctors and patients to enact evidence-based
shared decision making, a computerised tool, DARTSII, was
developed for patients with atrial fibrillation (AF). The
development of the DARTSII decision support tool and the
conduct of the RCT with its use have been described elsewhere.5
A key tenet of shared decision making is the need to
incorporate patient values into decision-making models.5
Mechanisms to elicit patient values have built upon economic
methods that focus on the construction of individual utility.
Standard gamble and time trade-off methods for elicitation of
values have been used in decision aids in healthcare.6 7
Although there is limited experience of use of standard gamble
methods in a shared decision-making context, problems using
the standard gamble in other contexts are reported in the
economics literature.8 In the DARTSII, the explicit elicitation of
participant values was conducted using the standard gamble
method to inform the decision analytical phase of the decision
support tool (fig 1).5 In the standard gamble component of the
intervention, participants were presented with a series of
hypothetical options for health states—for example, a choice
between (A) the certainty of a mild stroke or (B) a gamble, a
50% risk of death, with a corollary 50% chance of normal health
(fig 1). The hypothetical options presented to participants then
changed with option A remaining the same, and the risk of
death changing in comparison to the risk of normal health in
option B. The purpose of this exercise was to find the point of
indifference between two choices, in this case two health states:
option A (eg, certain stroke) and option B (a gamble, full health
or death). At the point at which the participant can no longer
decide between options A and B, a value between 0 and 1 is
derived demonstrating patient values for the health states,
where 0 = death and 1 = normal health. This value, described
as a utility for the health state, is then built into the decision
analysis as a measure of the participant’s values regarding
health.
Abbreviations: AF, atrial fibrillation; DARTSII, Decision Analysis in
Routine Treatment Study II; RCT, randomised controlled trial
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The pilot study accompanying the development phase
demonstrated good levels of acceptability and satisfaction with
the tool, and confidence in its usability.5 We note, however, that
the role of participants in the development phase was to help
develop the tool; an inevitably positive orientation to the
intervention in contrast with the participants in the trial, who
had a range of reasons for engagement related to testing the
tool.9 An RCT of the DARTSII tool comprising three arms, called
here explicit, implicit and guidelines arms (box 1), was
subsequently undertaken10. Each arm of the trial was delivered
by a single doctor. The doctors involved in the trial received
training in using the computerised decision support tool or the
guidelines in their respective arm of the trial. Individual
participants were randomly allocated to one of the arms.
Qualitative study of the RCT
A parallel qualitative study, Thematic Observational Analysis of
DARTSII, was conducted alongside the RCT of the DARTSII
decision support tool10 (fig 2). Multiple methods were used to
understand the interactional processes of the trial consultations
and participants’ experiences and understandings of the trial
and of any advice they were given. The first 30 participants
recruited to the RCT were invited to take part in the qualitative
study: explicit arm, n = 8; implicit arm, n = 11; guidelines arm,
n = 11. With participants’ consent, consultations (n = 29)
across the three arms of the trial were video recorded. The
video camera was positioned statically without an operator so
that the upper bodies of the doctor and the participant, and the
DARTSII tool (in arms one and two), were visible.
Participants subsequently took part in two semistructured
interviews. Within 5 days of the consultation, participants
(n = 30) were interviewed about general issues related to their
experience of AF, their experience of the consultation and their
understanding of how, and what, treatment decisions were
reached within it. Participants (n = 26) were interviewed for a
second time 90–100 days after the consultation. This interview
elicited participants’ views of the specific consequences they
attributed to the consultation, their post hoc evaluation of the
decision reached and the extent to which they believed that
their expectations had been met. Twenty-eight of the first and
all of the second semistructured interviews were audio taped
and transcribed with the respondent’s consent.
Transcripts of the consultations and interviews formed the
formal data for analysis, with field notes being used in the two
cases where permission to audio tape the interview was not given.
A constant comparative approach to the qualitative analysis of
text-based data was used,11 facilitated by QSR Nudist Software.
Video recordings were analysed using observational methods.12
Data were interpreted iteratively by a team experienced in
qualitative methods (RHG, BRH, CRM, MJM and TR). Thematic
categories within interview and video transcripts were identified
by category mapping and comparison.11 After identification of a
problem in the explicit arm of the trial, comparative analysis of
themes emerging from interview and video transcripts with
observation of the videos was conducted by BRH, MJM and TR.
Analysis was discussed and challenged in two joint meetings of
the qualitative and RCT teams.
The RCT and qualitative studies were carried out by two
teams (RCT comprising MPE, MJM, LS, RGT (PI); TOAD
comprising RHG, BRH, EFK, CRM (PI), MJM, TR) that were
funded and managed separately and worked in collaboration.
Ethical approval was granted for each study by the local
research ethics committee.
RESULTS
Concerns about the participants’ use of the standard gamble
exercise were first raised with researchers by a clinic doctor. He
was worried that participants did not grasp the purpose of the
exercise and reported difficulties working through the standard
gamble with them. Initial qualitative analysis of the consulta-
tion videos and concomitant analysis of the interviews revealed
that participants were confused about the use and purpose of
the standard gamble. Further in-depth analysis of video and
interview data (BRH, MJM, TR) confirmed that participants
experienced problems with both understanding and carrying
out the standard gamble. We present this analysis below. We
Figure 1 Sample entry screen for standard gamble exercise.
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examined the videos and post hoc interviews for confirming
and disconfirming examples of these problems and determined
that six of eight participants in this explicit arm experienced
these problems, and were unable to carry out the standard
gamble exercise. Two participants who did ‘‘get it’’ did so
immediately and were able to undertake nuanced discussions
of risk and risk calculations. Restrictions of space do not allow
us to present extracts for each participant. Rather, representa-
tive examples are used below to explain our analysis of the
problems encountered by participants. We have used the
following transcription system in this paper: Words in double
brackets—for example, ‘‘((laughs))’’—contain author’s com-
ments and generally refer to non-verbal actions of the
participants. Pauses are marked in tenths of a second—for
example, ‘‘(0.5)’’ is a 0.5 s silence and ‘‘(1.0)’’ is a 1 s silence.
With very short turns, acknowledgement tokens like ‘‘Yeah’’
and ‘‘Right’’, square brackets are used to denote these brief
enunciations—for example, ‘‘[Yeah]’’—and are positioned
within the text of the other speakers’ ongoing turn of talk.
Pseudonyms are used throughout.
In the extract below, the clinic doctor describes to one of the
participants, Geoff, the options available within the standard
gamble component. At the beginning of the consultation, the
clinic doctor gave a full explanation of the standard gamble
component, reiterating this during the consultation. The
hypothetical options presented here are between (A) the
certainty of a gastrointestinal bleed and (B) shifting odds of
normal health or mild stroke. In reiterating the description of
the options, the clinic doctor finished by checking Geoff’s
understanding. That the options are unclear and somewhat
confusing to Geoff is evident both in his response to the
question and in his making absolute the odds in option B in his
question of clarification, ‘‘do I have to take the mild stroke and,
to have normal health?’’ (table 1).
Later in the consultation, Geoff stated his confusion about
the content of the standard gamble. He expressed difficulty
comprehending the new set of options placed before him
(table 2).
In interview, Geoff described his difficulty in understanding
the standard gamble as part of a generalised difficulty with
computers: ‘‘Well I don’t know I understand them to be honest.
I cannot even put the bloody thing on and that. I’m hopeless at
that.’’ We cannot conclude, however, from this that computers
are the cause of Geoff’s difficulty in understanding the
standard gamble; this statement is arguably a face-saving
strategy,13 since not understanding computers (a technical
inability) may be a more acceptable explanation than not
understanding the content and the process (a cognitive
inability).
Another account of not understanding the standard gamble
exercise comes from Anne (table 3).
Anne stated that she found the exercise ‘‘baffling’’. Of
importance in this extract is Anne’s account of ‘‘just guessing’’.
The extract gives the sense in which Anne is simply trying to get
to the end of the process and perhaps saying what will get her
Box 1: Description of the arms of the trial
N The explicit Decision Analysis in Routine Treatment Study
II (DARTSII) decision support tool: a series of screens that
explicitly elicit the participant’s values through the
standard gamble method; an individualised risk and
benefit assessment and communication screen; a screen
suggesting the participant’s treatment preference given
their answer to the standard gamble questions and their
individualised risk using a Markov model decision
analysis; a shared decision-making section (fig 2).
N The implicit DARTSII decision support tool: an individua-
lised risk and benefit assessment and communication
screen; a shared decision-making section.
N The guidelines decision support tool: paper-based guide-
lines—this third arm acted as the control arm and was
understood as a routine consultation using the best
available evidence providing direct advice to the
participant (ie, not shared decision making).
Figure 2 Graphical representation of the components of, and the relationship between, the Decision Analysis in Routine Treatment Study II (DARTSII) trial
and the Thematic Observational Analysis of DARTSII (TOAD), the qualitative process evaluation.
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to that end more quickly. In the video observation Anne is
visibly agitated, and in the latter part of the standard gamble
she was increasingly ill at ease, seeking reassurance from the
carer she brought with her and at moments clasping her head
in her hands. Like Geoff, in the interview, Anne looks for
explanations for her inability to understand the standard
gamble: being ‘‘too old’’ and her ‘‘memory wasn’t working’’.
Problems with understanding and carrying out the standard
gamble clearly caused confusion to some participants, and in
two participants, Anne and Paul (below), this was manifest
visibly in the videos of consultations. One possibility is that
participants find it difficult to separate the concept of the
hypothetical risks from their own individual risk. In consider-
ing the options during the standard gamble where she
verbalised her choices, Anne talked as though the options
related directly to her rather than being a hypothetical
situation, and was reminded on a number of occasions by the
clinic doctor and her carer that these were hypothetical
examples and not about her personal clinical circumstances.
A further demonstration of this conflation of the hypothetical
and the real is evident in the extract from Paul’s consultation
below. In the discussion of mild or severe stroke, Paul refers
back to a personal experience of stroke with a family member.
This description becomes the lynchpin for his subsequent
responses to the options available (table 4).
Paul’s firm conviction that he would rather die than have a
stroke, be it mild or severe, evidently expresses his strongly held
values. At times during the interchange, Paul appeared to be
sweating profusely, mopping his brow with a white hand-
kerchief at frequent intervals. His agitation was further
evidenced in his manner of increasingly rocking backwards
and forwards in his seat towards and away from the computer
as the standard gamble exercise progressed. He did not exhibit
these behaviours either in the opening or in the later phases of
the clinic consultation; rather, he sat back in his chair, nodding
affirmations to the clinic doctor. Paul took approximately
20 min to complete the standard gamble component of the tool,
in contrast to Dave (below) who completed the standard
gamble in approximately 11 min.
Dave and another participant seemed to have little difficulty
with the standard gamble exercise. Dave explained his aptitude
for the exercise through his understanding of playing the odds
as a gambler (table 5).
For Dave the exercise made sense and, it could be argued,
produced a measure of his values that was derived from their
deliberate assessment of his value states (table 6).
Here, Dave orients to the standard gamble exercise as an
exercise in ‘‘odds’’, which provide ‘‘an option’’. This contrasts
with Geoff, Anne and Paul who orient to the standard gamble
as personalised to them. Although Dave was able to carry out
the standard gamble, it is not necessary that he understood its
purpose or relationship with the decisions he was making.
Indeed, he attributed it to the computer in making these
decisions (table 7).
On the basis of the analysis of the videos and interviews,
there was considerable discussion about the importance and
implications of these findings among members of the qualita-
tive study team. Informal detailed discussion between members
of the qualitative team and the principal investigator for the
RCT led to formal discussion of the issue, incorporating the
qualitative evidence, at one of the regular joint meetings of the
qualitative and RCT research teams. At this meeting, the
decision was taken to discontinue the explicit arm of the trial
on the basis of the qualitative analysis, which demonstrated
that the standard gamble value-elicitation exercise was causing
confusion and was unlikely to produce valid data on patient
values. It was believed that it would be unethical to continue,
and also that the results would be distorted or impossible to
interpret. Approval for revisions to the protocol was granted by
the funding body and the local ethics committee.
DISCUSSION
The process of identifying a problem in the explicit arm of the
trial was an iterative one, occurring across multiple analyses of
video-based data, consultation and post hoc interview tran-
scripts and conversations by, within and between members of
the qualitative study team and the RCT team. The initial
identification of the problem using the explicit arm of the trial
was raised by one of the clinic doctors in the RCT, but the
opinions of one individual were not themselves sufficient
evidence to warrant cessation of that arm of the trial. We
required evidence from the trial itself. Careful analysis of
participants’ use of the decision support tool allowed us to
demonstrate the specific problems encountered by these
participants, and to examine their potential effects on validity
in the trial. Regarding the decision to suspend the explicit arm,
the two teams worked in concert to address complex
methodological and ethical questions raised by participants’
reactions to the values elicitation exercise, the standard gamble.
It was clear that most (6/8) participants were unable to easily
carry out the values elicitation exercise. While two participants
could carry out the standard gamble exercise, none appeared to
understand the purpose of the elicitation of values in relation to
the decision-making tool. Understanding is of course produced
in the communication and interaction between the doctor and
the participant. Nonetheless, as we illustrate in the extracts
above, the explanations of the standard gamble, although
accurate, are not easy to understand. On the basis of our
analysis, we cannot be sure that the numerical results produced
by this instrument would accurately reflect participants’ values.
Table 1 Video transcript: fragment (151Exp: lines
404–15)
Dr A So, option A is having the stomach bleed where you’re in hospital for
a week and you have a blood transfusion but after that you’re okay
[mm hm]. Option B is basically running a risk of either not having the
stomach bleed, normal health or having a mild stroke. If it was fifty
fifty between the normal health and the mild stroke, would you prefer
option A, the stomach bleed, or option B, the risk of a mild stroke and
normal health?
(3.0)
Dr A Do you understand that one?
Geoff No, not really. [mm] Do I have to take the mild stroke and, to have
normal health?
Dr A No [or] if things, this is a treatment option B where if it goes well you
don’t have a stomach bleed and you don’t have a mild stroke.
Table 2 Video transcript: fragment (151Exp: lines
456–72)
Dr A So, so this option is where the, the odds are, but the alternative is to
choose to have a stomach bleed
Geoff Mm hm
(0.5)
Dr A Do you understand?
Geoff No er (1.5) not really, I’m still
Dr A Still a bit puzzled by this one
Geoff Yeah, yeah, I am
Dr A It’s switched it around a bit’ cause the strokes were over here last
time and they weren’t an option with this. Option A
Geoff Is a stomach bleed
Dr A Is a stomach bleed [Yes, yes, yes] where you go into hospital and
you’re well afterwards, you have your transfusion [mm hm]
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This raised questions about how validly to interpret these
results in the trial analysis. Furthermore, all participants who
were unable to easily carry out the standard gamble exercise
exhibited signs of discomfort and/or agitation; two participants
palpably manifested anxieties during the consultation. For the
research teams this raised ethical issues about duty of care for
the participants.
Methodological issues
The decision to cease the explicit arm of the trial was made for
methodological and ethical reasons. The decision was made at
an early stage, after there were only eight participants in the
discontinued arm. These may not have been representative of
all potential participants. Nonetheless, we believed that the
findings threw sufficient doubt on the application of the
intervention that there was an imperative to act rather than
submit others to an intervention that was at best confusing.
Any results would have been produced by an apparently
malfunctioning intervention and we believed that continuation
of this would be unethical.
One explanation for the findings might be that the arms of
the trial were not carried out effectively or that the interven-
tions were flawed to begin with. However, an extensive
development process was undertaken and, as described above,
the tools were shown to be acceptable and have utility.5
Furthermore, trial doctors were given thorough training in
the conduct of each arm of the trial. It is possible that the
participants involved in the development of the trial were
different from those in the trial itself: participants in the
development phases were selected by their general practi-
tioners, whereas those in the RCT were selected from the
population of patients with AF. Moreover, participants in each
phase consented to different types of involvement, which may
have introduced selection bias on the basis of participant
motivation for involvement. In the development phase, the task
for participants was different from those in the trial. Hence, the
consent processes and the expectations of participants were
different from those at the development stage. This may explain
why the problems identified in the trial were not apparent in
the development and pilot phases. Further, as we have
demonstrated elsewhere, the context of the research clinic
setting and the RCT itself produces different orientations to the
study and to the decision support tool, and this influences the
conduct of the trial in ways that cannot be predicted or
reproduced in a pilot study.9 14
This study does not enable us to conclude that the standard
gamble is without utility in eliciting participants’ values; two of
our participants were able to carry out the exercise without
difficulty, although not necessarily with a full understanding of
its purpose. Also, we are not able to simply attribute difficulty
using the standard gamble exercise to elicit values to a
deficiency on the part of participants; these participants had
already successfully negotiated lengthy and complex informa-
tion and consent processes required to take part in the two
studies. It may be that the standard gamble could form part of
an array of processes for eliciting participants’ values. We were
able to demonstrate here the value of the qualitative components
of the qualitative study to scrutinise methodological validity and
in enabling a decision to act ethically in the context of the trial.
Table 3 Interview transcript (68Exp: lines 565–73)
Anne So I was just sort of thinking (0.5) more or less just guessing
probably but em, no, it seemed to have us a bit er, baffled that.
Going from one to the other, you know
Int’er Yeah
Anne Different things. That had us a bit baffled, and I thought, well I was
saying two years or less than five years and something, and then
three years and I thought, oh God. So at the finish I was just
guessing, (0.5) just to say, you know. Em, I think I’m getting too old
to take things in like that ((laughs)). Me memory wasn’t working
Table 4 Video transcript: fragment (45Exp: lines 120–38
and 161–8)
Dr A Now it’s change it again so that the odds are getting worse, so
only 30 in 100 would stay in normal health, but 70%, 70 in 100
would die
Paul Everybody dies so we have got to try and get a life! [okay] that’s
the whole object, yep
Dr A And again 20 in 100, [yes, yes, yes] you would still carry on?
Paul I would prefer to try and keep myself alive than just lie down!
Dr A Right (2.0) This doesn’t lead to death you realise
Paul No. I know I know
Dr A It just leads to you being, erm going back to this state ((doctor
points to the screen)) where you are just a bit weak, your speech is
a bit slurred, and that would carry on for the rest of your life [yep]
yeah?
Paul I have seen that condition in people in, [right] a member of the
family
Dr A And you wouldn’t want
Paul who had a mild stroke, and (0.5)
Dr A You would prefer not to
Paul Put him in for three months and when he came out, he was at
home for a few years then he had a major stroke
((Section omitted—lines 139–161))
Dr A So if you had a one in a thousand chance of returning to normal
life you would still take it? Right what about one in 10 000?
Paul It’s better than nothing isn’t it, it’s the same odds
(0.5)
Dr A Okay, so you would take that?
Paul Yeah, yeah,
Dr A So that’s why you stopped?
Paul You’d take the chance to live
Table 5 Interview transcript: (94Exp: 5–14)
Int’er How did you feel when you had to answer the questions, you know
when the doctor was asking you to imagine how you would feel and
then asked you to choose between say, for example a mild stroke or
forty sixty percent of something else, how did you feel answering
those questions?
Dave No bother. You see I’m a gambler. I do gamble. It’s not a fixation
with us but I do gamble so I just put them in percentages in me mind, I
just worked out what percentage would be best for what.
Table 6 Video transcript: fragment (94Exp: lines 103–16)
Dr A It’s changed it so that it’s increased your risk of , the, the-ye- your
chance of the treatment giving you normal health to 60% [mm hm]
and reduced the chance of dying to 40% chance [mm] from this
treatment. So the question again is would you rather have the
treatment or would you rather stay with, have the mild stroke?
Dave I think even at those odds I’d stay with the mild stroke
Dr A Right, okay (2.2) As you can see it’s changed it again [Yeah] and it’s
going to carry on changing it, [mm] so giving you a 30% chance of
dying compared with the mild stroke or a 70% chance of you
returning to normal health
(2.2)
Dave I think, I think I’d still stay with the er, mild stroke as an option at the
moment
Dr A Right (1.5) okay, let’s change it further, 80% chance of normal
health, 20% chance of death as opposed to a mild stroke?
Dave Errrm (3.5) I may change my action now, to try the normal health
now
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Qualitative methods in RCTs
That qualitative research can fulfil the roles outlined in the
MRC guidelines, specifically as part of pre-intervention devel-
opment and post hoc interpretation, is well established.15–17 A
key advantage of integrating qualitative research, particularly
qualitative process evaluation, in RCTs is that they allow us to
examine social processes and practices engaged in, for example,
the use of new technologies18 19 and thereby gain an under-
standing about the production of knowledge in particular RCTs.
In this study, we have demonstrated the manner in which
qualitative process evaluation may contribute to monitoring
and auditing trial conduct, and ensuring felicity to the principle
of non-maleficence, in parallel and complementary ways to
data monitoring committees of RCTs. Further, qualitative
methods can be used to evaluate the validity of measures used
in a trial in situ—that is, in the local and particular
circumstances of particular trials. Notwithstanding these
benefits, the incorporation of qualitative research methods
may have an adverse effect on recruitment to the trial where
additional commitments are required from participants. Any
such selection bias would affect the interpretation of the trial,
particularly its generalisability. The question of whether a
selection bias is introduced by additional qualitative compo-
nents in a trial requires further examination.
CONCLUSION
We have demonstrated here the use of qualitative methods in
examining the processes of a trial, in raising methodological and
ethical questions about the conduct of the trial and in providing
evidence to take action on those questions where necessary.
Although the role of qualitative process evaluation to raise
methodological and ethical issues has been discussed elsewhere,20
this is the first demonstration of the use of qualitative evidence to
take action to discontinue an intervention arm of a trial. We argue
that, in addition to acting as a pre and post hoc adjunct to
improving and understanding trials of complex interventions,
qualitative evidence can inform decision making about the
continuation or cessation of a trial or its component interventions.
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Table 7 Interview transcript: (94Exp: 5–14)
Dave I think the decision was that I shouldn’t take warfarin and I should go
onto aspirin but it was just the computer’s decision based on
percentages of em, life, death and strokes etcetera if I do and if I
don’t you know. Em, funny bloody questions. Have you ever seen
them?
Int’er On the tool? I’ve been through it once
Dave Funniest questions. I mean percentage of this getting greater all the
time and you’ve got to put a stopping point somewhere, thirty
percent to seventy percent, you’d have a stroke if you took warfarin,
then fifty fifty, then seventy thirty, you’re saying one thing one time,
you’ve got to put a stop when it gets to eighty twenty, you know, it’s
funny questions
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